Accès gratuit
Numéro
Med Sci (Paris)
Volume 32, Numéro 6-7, Juin–Juillet 2016
Page(s) 606 - 611
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20163206024
Publié en ligne 12 juillet 2016
  1. Clement LC, Avila-Casado C, Macé C, et al. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 2011 ; 17 : 117–122. [CrossRef] [EDP Sciences] [PubMed]
  2. Nachman PH, Jennett JC, Falk RJ. Primary glomerular disease. In : Taal MW, Chertow GM, Marsden PA, et al., eds, The kidney 9th ed. Philadelphia : Elsevier, 2012 : 1100–1191.
  3. Faul C, Donnelly M, Merscher-Gomez S, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008 ; 14 : 931–938. [CrossRef] [PubMed]
  4. Müller-Deile J, Schiffer M. Podocyte directed therapy of nephrotic syndrome – can we bring the inside out? Pediatr Nephrol 2015 ; 31 : 393–405. [CrossRef] [PubMed]
  5. Macé C, Clément LC. Implication d’Angptl4 dans le syndrome néphrotique. Med Sci (Paris) 2014 ; 30 : 605–607. [CrossRef] [EDP Sciences] [PubMed]
  6. Brideau G, Doucet A. Over-expression of adenosine deaminase in mouse podocytes does not reverse puromycin aminonucleoside resistance. BMC Nephrol 2010 ; 11 : 15. [CrossRef] [PubMed]
  7. Zhang H, Schin M, Saha J, et al. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice. Am J Physiol Renal Physiol 2010 ; 299 : F91–F98. [CrossRef] [PubMed]
  8. Michael AF, Blau E, Vernier RL. Glomerular polyanion. Alteration in aminonucleoside nephrosis. Lab Invest 1970 ; 23 : 649–657.
  9. Miner JH. Glomerular filtration: the charge debate charges ahead. Kidney Int 2008 ; 74 : 259–261. [CrossRef] [PubMed]
  10. Bertozzi CR, Freeze HH, Varki A, Esko JD. Glycans in biotechnology and the pharmaceutical industry. In : Varki A, Cummings RD, Esko JD, et al., eds, Essentials of glycobiology, 2nd Edn. New York : Cold Spring Harbor Press, 2009 : 719–732.
  11. Varki A, Schauer R, Varki A, Cummings RD, Esko JD, et al. Sialic acids. Essentials of glycobiology, 2nd Edn. New York : Cold Spring Harbor Press, 2009 : 199–217.
  12. Chou HH, Takematsu H, Diaz S, et al. A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci USA 1998 ; 95 : 11751–11756. [CrossRef]
  13. Chugh SS, Clement LC, Macé C. New insights into human minimal change disease: lessons from animal models. Am J Kidney Dis 2012 ; 59 : 284–292. [CrossRef] [PubMed]
  14. Luchansky SJ, Yarema KJ, Takahashi S, Bertozzi CR. GlcNAc 2-epimerase can serve a catabolic role in sialic acid metabolism. J Biol Chem 2003 ; 278 : 8035–8042. [CrossRef] [PubMed]
  15. Malicdan MC, Noguchi S, Hayashi YK, et al. Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model. Nat Med 2009 ; 15 : 690–695. [CrossRef] [PubMed]
  16. Clement LC, Macé C, Avila-Casado C, et al. Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome. Nat Med 2014 ; 20 : 37–46. [CrossRef] [PubMed]
  17. Koliwad SK, Kuo T, Shipp LE, et al. Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism. J Biol Chem 2009 ; 284 : 25593–25601. [CrossRef] [PubMed]
  18. Koskimies O, Vilska J, Rapola J, Hallman N. Long-term outcome of primary nephrotic syndrome. Arch Dis Child 1982 ; 57 : 544–548. [CrossRef] [PubMed]
  19. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr.. Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 1997 ; 8 : 769–776. [PubMed]
  20. Chugh SS, Macé C, Clément LC, et al. Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease. Front Pharmacol 2014 ; 5 : 23. [CrossRef] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.